Isolate | Antibiotic resistance profilea |
---|
TZP | CAZ | MEM | IMP | ATM | GEN | TOB | AK | SXT | CIP |
---|
CF349b |
May 2008 | S | S | R | R | I | R | R | S | R | I |
December 2009 | S | I | NA | R | R | R | R | R | R | R |
March 2010 | S | S | NA | R | R | R | R | R | R | R |
July 2010 | R | S | S | NA | R | R | R | R | R | R |
CF352c |
July 2008 | S | S | R | R | I | R | R | R | R | S |
December 208 | I | S | R | R | R | R | R | R | R | I |
- aS sensitivity, I intermediate resistance, R resistance. Antibiotic abbreviations: TZP piperacillin/tazobactam, CAZ ceftazidime, MEM meropenem, IMP imipenem, ATM aztreonam, GEN gentamicin, TOB tobramycin, AK amikacin, SXT trimethoprim/sulfamethoxazole, CIP ciprofloxacin
- bCF349 = B. contaminans strain isolated from Patient 1 in May 2008
- cCF352 = B. contaminans strain isolated from Patient 2 in June 2008